Psychiatric polypharmacy: A clinical approach based on etiology and differential diagnosis

Harvard Review of Psychiatry

Volumn 20, Issue 2, 2012, Pages 79-85

  Freudenreich, Oliver ^a   Kontos, Nicholas ^a   Querques, John ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

differential diagnosis; etiology; polypharmacy; professionalism

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CLOZAPINE; METFORMIN; NEUROLEPTIC AGENT; OLANZAPINE; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR;

ANXIETY DISORDER; CLINICAL PRACTICE; DEPRESSION; DIFFERENTIAL DIAGNOSIS; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HUMAN; METABOLIC SYNDROME X; PHYSICIAN; POLYPHARMACY; PRESCRIPTION; PRIORITY JOURNAL; PROFESSIONALISM; PSYCHIATRIC TREATMENT; REVIEW; RISK ASSESSMENT; SCHIZOPHRENIA; SOCIETY;

DIAGNOSIS, DIFFERENTIAL; HUMANS; MENTAL DISORDERS; POLYPHARMACY; PSYCHIATRY;

EID: 84859966467     PISSN: 10673229     EISSN: 14657309     Source Type: Journal    
DOI: 10.3109/10673229.2012.677358     Document Type: Review

References (40)

1. Ghaemi SN, ed. Polypharmacy in psychiatry. Basel, Switzerland: Marcel Dekker, 2002.
2. Mojtabai R, Olfson M. National trends in psychotropic medication polypharmacy in office-based psychiatry. Arch Gen Psychiatry 2010;67:26-36.
3. Baandrup L, Allerup P, Nordentoft M, Lublin H, Glenthoj BY. Exploring regional variation in antipsychotic coprescribing practice: a Danish questionnaire survey. J Clin Psychiatry 2010;71:1457-64.
4. Owen RR, Fischer EP, Kirchner JE, et al. Clinical practice variations in prescribing antipsychotics for patients with schizophrenia. Am J Med Qual 2003;18:140-6. (Pubitemid 37026133)
5. SernyakMJ, Rosenheck R. Clinicians' reasons for antipsychotic coprescribing. J Clin Psychiatry 2004;65:1597-600.
6. Ghaemi SN. "All the worse for the fishes:" conceptual and historical background of polypharmacy in psychiatry. In: Ghaemi SN, ed. Polypharmacy in psychiatry. Basel, Switzerland: Marcel Dekker, 2002.
7. Carpenter WT Jr. Evidence-based treatment for first-episode schizophrenia? Am J Psychiatry 2001;158:1771-3. (Pubitemid 33054768)
8. Davidson M, Galderisi S, Weiser M, et al. Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST). Am J Psychiatry 2009;166:675-82.
9. Essock SM, Schooler NR, Stroup TS, et al. Effectiveness of switching from antipsychotic polypharmacy to monotherapy. Am J Psychiatry 2011;168:702-8.
10. Correll CU, Rummel-Kluge C, Corves C, Kane JM, Leucht S. Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials. Schizophr Bull 2009;35:443-57.
11. Zink M, Englisch S, Meyer-Lindenberg A. Polypharmacy in schizophrenia. Curr Opin Psychiatry 2010;23:103-11.
12. Rush AJ, Trivedi MH, Stewart JW, et al. Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. Am J Psychiatry 2011;168:689-701.
13. Ho DD, Bieniasz PD. HIV-1 at 25. Cell 2008;133:561-5. (Pubitemid 351636315)
14. Andreadis EA, Tsourous GI,Marakomichelakis GE, et al.Highdose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension. J Hum Hypertens 2005;19: 491-6. (Pubitemid 40767186)
15. Shorter E. Before Prozac: the troubled history of mood disorders in psychiatry. New York: Oxford University Press, 2009.
16. Taylor DM, Smith L. Augmentation of clozapine with a second antipsychotica meta-analysis of randomized, placebocontrolled studies. Acta Psychiatr Scand 2009;119:419-25.
17. Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurementbased care in STAR D: implications for clinical practice. Am J Psychiatry 2006;163:28-40. (Pubitemid 43050100)
18. Tobi H, Faber A, van den Berg PB, Drane JW, de Jongvan den Berg LT. Studying co-medication patterns: the impact of definitions. Pharmacoepidemiol Drug Saf 2007;16:405-11 (Pubitemid 46656862)
19. Freudenreich O, Goff DC. Polypharmacy in schizophrenia: a fuzzy concept [Letter]. J Clin Psychiatry 2003;64:1132.
20. Wu RR, Zhao JP, Jin H, et al. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial. JAMA 2008;299:185-93.
21. Freudenreich O, Querques J, Kontos N. Checklist psychiatry's effect on psychiatric education [Letter]. Am J Psychiatry 2004;161:930. (Pubitemid 38625360)
22. Kontos N, Freudenreich O, Querques J. Thoughtful diagnoses: not "checklist" psychiatry. Curr Psychiatry 2007;6:112.
23. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-97. (Pubitemid 41127293)
24. Velligan D, Sajatovic M, Valenstein M, et al. Methodological challenges in psychiatric treatment adherence research. Clin Schizophr Relat Psychoses 2010;4:74-91.
25. Mechanic D, Volkart EH. Stress, illness behavior, and the sick role. Am Sociol Rev 1961;26:51-8.
26. Pilowsky I. The concept of abnormal illness behavior. Psychosomatics 1990;31:207-13. (Pubitemid 20168110)
27. Klerman GL. Psychotropic hedonism vs. pharmacological Calvinism. Hastings Cent Rep 1972;2:1-3.
28. Kontos N, Querques J, Freudenreich O. The problem of the psychopharmacologist. Acad Psychiatry 2006;30:218-26
29. Ghaemi SN. Hippocrates and Prozac: the controversy about antidepressants in bipolar disorder. Prim Psychiatry 2006;13:51-8. (Pubitemid 44851654)
30. Fogel BS, Duffy J, McNamara ME, Salloway S. Skeptics and enthusiasts in neuropsychiatry. J Neuropsychiatry Clin Neurosci 1992;4:458-62.
31. Kontos N. Perspective: biomedicinemenace or straw man? Reexamining the biopsychosocial argument. Acad Med 2011;86:509-15.
32. Ackerknecht EH. Recurrent themes in medical thought. Sci Mon 1949;69:80-3.
33. Cook HJ. Good advice and little medicine: the professional authority of early modern English physicians. J Br Stud 1994;33:1-31.
34. Kontos N, Querques J, Freudenreich O. Fighting the good fight: responsibility and rationale in the confrontation of patients. Mayo Clin Proc 2012;87:63-6.
35. Paterniti DA, Fancher TL, Cipri CS, Timmermans S, Heritage J, Kravitz RL. Getting to "no": strategies primary care physicians use to deny patient requests. Arch Intern Med 2010;170:381-8.
36. Bishop R. Workarounds that work. How to conquer anything that stands in your way at work. New York:McGraw-Hill, 2011.
37. Scheurich N. The prescriber as moralist: values in the antidepressant debate. Perspect Biol Med 2006;49:199-208.
38. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed., text rev. Washington, DC: American Psychiatric Press, 2000.
39. Kant I. Grundlegung zur Metaphysik der Sitten. Riga, 1785.
40. Lesser CS, Lucey CR, Egener B, Braddock CH 3rd, Linas SL, Levinson W. A behavioral and systems view of professionalism. JAMA 2010;304:2732-7.